Navigation Links
Health Decisions CEO Michael Rosenberg Named a Business Leader Top Entrepreneur for 2013

DURHAM, N.C., May 6, 2013 /PRNewswire-iReach/ -- Health Decisions, Inc., the leader in improving clinical trial efficiency, today announced that Business Leader Magazine named CEO Michael Rosenberg , MD, MPH one of its 2013 Top Entrepreneurs in the Triangle area of North Carolina, one of the leading biotechnology hubs in the United States. Dr. Rosenberg was honored at an awards dinner April 25 at the Brier Creek Country Club in Raleigh, NC.


"Business Leader once again is thrilled to present these very special awards to honor and recognize the Triangle's leading entrepreneurs," said Stephen Reynolds , publisher of Business Leader. "The Triangle has such a strong, successful and diverse entrepreneurial community. Whether serving those in need or working on breakthrough innovations in health care, these winners are changing people's lives. We thank each of our finalists for years of hard work and passion to make a difference."

"I'm honored to be recognized by Business Leader following an outstanding year at Health Decisions," Dr. Rosenberg said. "Health Decisions extended its leadership in clinical research in areas such as adaptive monitoring, where our proprietary solution enables us to reduce cost and improve data quality simultaneously. Entrepreneurial spirit throughout our company drives the innovation that allows us to conduct large trials with market-leading efficiency. A 12,000-patient study of a colorectal cancer diagnostic and a 3,500-patient global contraceptive study are recent examples."

Each year since 1996, Business Leader has honored executive leaders in the Triangle through its Top Entrepreneur Awards, recognizing those who have demonstrated exceptional leadership attributes and innovative approaches to enhance their company's industry status. Honorees for 2013 included Raleigh Mayor Nancy McFarlane , CEO of MedPro Rx, a specialized pharmacy services company, and James Petrilla , President and CEO of BioAgilytix Labs, a bioanalytics firm.

About Health Decisions

Health Decisions is the leading clinical research organization (CRO) in Agile Clinical Trials, providing proactive trial management based on real-time actionable information, enabling decisions that reduce timelines, accelerate access to new medicines and medical devices and allow biopharmaceutical and device companies to seize market opportunities. Founded in 1989, Health Decisions has conducted a range of successful clinical trials demonstrating means of reducing financial risk and time to market, including drugs and biologics, and devices. Health Decisions is headquartered in Durham, NC and operates on all five continents.

Media Contact: Leslie Hammill Health Decisions, 9199671111,

News distributed by PR Newswire iReach:

SOURCE Health Decisions
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
2. Bayer HealthCares Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon
3. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
4. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
5. inVentiv Health Selected to Provide Sales Operations Support for Santarus
6. Masimo to Present at 23rd Annual Piper Jaffray Health Care Conference
7. Hong Kong Department of Health to Combat Sudden Cardiac Arrest With Powerheart AEDs
8. Nations Best Health Care Organizations for Patient Satisfaction, Core Measures Honored by Press Ganey
9. Sequenom Announces Participation at the 23rd Annual Piper Jaffray Healthcare Conference
10. SuperNova Diagnostics® to Present at the 23rd Annual Piper Jaffray Healthcare Conference in New York City
11. Health Diagnostic Laboratory, Inc. Provides Largest Corporate Gift in Science Museum of Virginias History
Post Your Comments:
(Date:11/24/2015)... 24, 2015 SHPG ) announced today that ... Piper Jaffray 27 th Annual Healthcare Conference in ... at 8:30 a.m. EST (1:30 p.m. GMT). --> SHPG ... will participate in the Piper Jaffray 27 th Annual Healthcare ... Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 p.m. GMT). ...
(Date:11/24/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... 11,000 post-share consolidation (or 1,100,000 pre-share consolidation) Series ... Warrants") subject to the previously disclosed November 1, ... which will result in the issuance of 365,518 ... issuance of such shares, there will be approximately ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... InSphero AG, ... 3D cell culture models, has promoted Melanie Aregger to serve as Chief Operating Officer. ... Aregger served on the management team and was promoted to Head of ...
(Date:11/24/2015)... ANGELES , Nov. 24, 2015 ... biotechnology company focused on the discovery, development and commercialization ... , Ph.D., Chief Executive Officer, is scheduled to present ... 1, 2015 at 10:50 a.m. EST, at The Lotte ... City . . ...
Breaking Biology Technology:
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has ... to provide preclinical development services to the National Cancer ... SRI will provide scientific expertise, modern testing and support ... of preclinical pharmacology and toxicology studies to evaluate potential ... --> The PREVENT Cancer Drug Development Program is ...
(Date:10/29/2015)... , Oct. 29, 2015  The J. Craig Venter ... titled, "DNA Synthesis and Biosecurity: Lessons Learned and Options ... of Health and Human Services guidance for synthetic biology ... --> --> ... has the potential to pose unique biosecurity threats. It ...
(Date:10/29/2015)... , Oct. 29, 2015  Rubicon Genomics, Inc., ... U.S. distribution of its DNA library preparation products, ... Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has ... preparation of NGS libraries for liquid biopsies--the analysis ... and prognostic applications in cancer and other conditions. ...
Breaking Biology News(10 mins):